Most Read Articles
4 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 5 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 2 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Hypertensive emergencies, urgencies prevalent in EDs

01 Jul 2020
The accused nurses failed to respond to the patient’s ventilator alarm in a timely manner, resulting in her death

Some of the common causes of access to emergency departments (EDs) are hypertensive emergencies and hypertensive urgencies, with the latter occurring more frequently, results of a study have shown.

“Blood pressure (BP) levels alone do not reliably predict the presence of acute hypertension-mediated organ damage (aHMOD), which should be suspected according to the presenting signs and symptoms,” the investigators said.

This systematic review and meta-analysis examined the prevalence of hypertensive emergencies and hypertensive urgencies in EDs, as well as the relative frequency of aHMOD subtypes, and evaluated the clinical variables associated with aHMOD.

The investigators conducted a systematic literature search on the databases of PubMed, Ovid, and Web of Science from inception to 22 August 2019. Two independent investigators extracted study-level data for a random-effects meta-analysis.

Eight studies, including 1,970 hypertensive emergencies and 4,983 hypertensive urgencies, met the eligibility criteria. The prevalence of hypertensive emergencies and hypertensive urgencies was 0.5 percent and 0.9 percent, respectively (odds ratio, 2.5, 95 percent confidence interval, 1.4–4.3).

The most common subtype of aHMOD was pulmonary oedema/heart failure (32 percent), followed by ischaemic stroke (29 percent), acute coronary syndrome (18 percent), haemorrhagic stroke (11 percent), acute aortic syndrome (2 percent), and hypertensive encephalopathy (2 percent). BP levels at presentation showed no clinically meaningful differences.

Patients with hypertensive urgency were 5.4 years younger than those with hypertensive emergency and more often complained of nonspecific symptoms or headache. On the other hand, the latter more often had specific symptoms.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 5 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 2 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.